FACULTY
MEET OUR FACULTY
DR. NEELIMA SHRIVASTAVA
Assistant ProfessorProfile
Neelima Shrivastava has done M. Pharm in Pharm. Chemistry from Jamia Hamdard University in 2016 Qualified AICTE-GPAT; B. Pharm from RGPV University, Bhopal 2014 with First Division. Ph.D. form Jamia Hamdard University in 2023. She has also served as SRF-ICMR during her Ph.D. She has more than 05 years of experience in Academia, Research & Healthcare. Her area of research is Pharmaceutical Chemistry, Synthesis of hybrid heterocyclic compounds, Anticancer screening of compounds. She has more than 10 publications and 1 book chapters in indexed & reputed publishing houses, with more than 200 citations and i10-Index of 7. She has attended more than 10 National & International Seminars/Conferences/Workshops/FDPs/QIPs, and presented more than 10 papers.
LinkedIn Profile
Linkedin.com/in/dr-neelima-s-739206276Education
- M. Pharm (Pharm. Chemistry), Ph.D.
- Ph.D. (Pharmaceutical Chemistry), Jamia Hamdard University, New Delhi. (2023)
- Master of Pharmacy in Pharmaceutical Chemistry, Jamia Hamdard University, New Delhi. (2016)
- Bachelor of Pharmacy, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal. (2014)
Research
Google scholar
ORC iDAwards & Recognition
- Received 1st position in poster presentation in Bacterial Host, from Shri Ram Institute of Technology, Jabalpur.
- Received ICMR SRF grant in year 2019.
Experience
- 3 Years
Areas of Specialization / Research Interests
- Cancer Research
- Molecular Docking
- Synthesis of Hybrid-heterocyclic compounds
Publications / Key Publications
- Shrivastava N, Naim MJ, Alam MJ, Nawaz F, Ahmed S, Alam O. Benzimidazole scaffold as anticancer agent: synthetic approaches and structure–activity relationship. Archiv der Pharmazie. 2017 Jun;350(6):e201700040.[Impact factor: 3.6]
- Rashid M, Shrivastava N, Husain A. Synthesis and sar strategy of thiazolidinedione: A novel approach for cancer treatment. Journal of the Chilean Chemical Society. 2020 Jun;65(2):4817-32. [Impact factor: 1.253]
- Husain A, Meenakshi DU, Ahmad A, Shrivastava N, Khan SA. A review on alternative methods to experimental animals in biological testing: recent advancement and current strategies. Journal of Pharmacy and Bio allied Sciences. 2023 Oct 1;15(4):165-71. [Impact factor: 0.9]
- Shrivastava N, Husain A, Rashid M, Alsabeelah NF, Karim S, Siddiqui NA. Recent advances towards treatment of HIV: synthesis and SAR studies. Mini Reviews in Medicinal Chemistry. 2021 Mar 1;21(4):471-99. [Impact factor: 3.3]
- Naim MJ, Alam O, Alam MJ, Alam P, Shrivastava N. A review on pharmacological profile of morpholine derivatives. Int. J. Pharmacol. Pharm. Sci. 2015;3(1):40-51. [Impact factor: 8.15]
- Shrivastava N, Khan SA, Alam MM, Akhtar M, Srivastava A, Husain A. Anticancer heterocyclic hybrids: Design, synthesis, molecular docking and evaluation of new thiazolidinone-pyrazoles. Zeitschrift für Naturforschung B. 2023 Feb 1;78(1-2):1-6. [Impact factor: 1.0]
- Shrivastava N, Khan SA, Ahmad S, Al-Balushi K, Husain A. Recent advances in the development of chemotherapeutic agents for malaria. Mini Reviews in Medicinal Chemistry. 2021 Jul 1;21(12):1487-508. [Impact factor: 3.3]
- Khan SA, Shrivastava N, Akhtar MJ, Ahmad A, Husain A. Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections. Asian Pacific Journal of Tropical Medicine. 2024 Jul 1;17(7):285-98. [Impact factor: 3.014]
- Haider K, Shrivastava N, Pathak A, Dewangan RP, Yahya S, Yar MS. Results in Chemistry. [Impact factor: 4.2]
Patents
- Patent No: 407412-001 Biosensor Device For the Detection of Cancer Cells, Status: Granted on 5/04/2024.
- A Herbal Gel Formulation for the treatment of gingivitis and periodontitis, status: Applied.
Courses Taught
- B. Pharm
- Medicinal Chemistry-I, Medicinal Chemistry-II, Inorganic Chemistry
- M. Pharm
- Food Analysis
Supervision
- PhD-01(Ongoing)
Conference / Workshops Attended / Invited Talks
- Conferences: 06
- Workshop: 03